GLA From Evening Primrose.

Delta-6 desaturase and the elongase that carries GLA on to DGLA depend on magnesium. Adequate magnesium keeps the conversion step from stalling at the point GLA enters.

Delta-6 desaturase activity falls when zinc status is low, and that is the step that makes GLA from linoleic acid. Supplying preformed GLA plus zinc covers both the bypass and the native route.

B6 is one of the cofactors supporting delta-6 desaturase activity in the essential fatty acid chain.

Biotin is the cofactor for acetyl-CoA carboxylase, which supplies the malonyl-CoA units elongases use to extend GLA to DGLA. Low biotin slows the elongation step downstream of the oil itself.

GLA carries three double bonds and oxidises readily in the capsule and in membranes. Tocopherols sit in the lipid phase and quench the chain reaction, which is why almost every GLA oil is formulated with vitamin E.

DGLA made from GLA can be elongated onward toward arachidonic acid, and EPA slows that delta-5 desaturase step, so the DGLA pool stays where it is wanted.

EPA competes at delta-5 desaturase and at the same cyclooxygenase enzymes, holding the arachidonic branch in check while DGLA accumulates.

Black currant oil supplies GLA alongside stearidonic acid, which enters the omega-3 chain past the delta-6 step. The pair covers both branches of the essential fatty acid tree from one lipid base.

Ascorbate reduces the tocopheryl radical back to tocopherol at the membrane surface after it has quenched a lipid radical. In a polyunsaturated oil that recycling keeps the vitamin E working for longer.

Ginkgolides antagonise platelet activating factor while DGLA-derived series-one prostaglandins reduce platelet aggregation. The two act on normal clotting in the same direction, so the effect adds rather than balances.

Garlic organosulfur compounds lower platelet aggregation by a route separate from prostaglandin balance. Combined with a GLA oil the effects on normal clotting stack.

Astaxanthin spans the lipid bilayer and quenches radicals at both membrane surfaces, where polyunsaturated chains are most exposed. It complements tocopherol rather than duplicating it.

Linoleic acid is the dietary starting point and delta-6-desaturase inserts the double bond that makes it gamma-linolenic acid. Supplying preformed GLA from evening primrose oil bypasses that step, which is the whole rationale for the ingredient. The two therefore sit on the same pathway rather than acting independently.

Delta-6-desaturase, elongase 5 and delta-5-desaturase handle both the omega-3 and omega-6 families, and the enzymes have a higher affinity for the omega-3 substrates. Adding long-chain omega-3 shifts the balance of tissue fatty acids away from the omega-6 arm while GLA pushes the other way. This is a substrate competition to be aware of when combining, not a reason to avoid either.

Alpha-linolenic acid from flaxseed is the preferred substrate for the same delta-6-desaturase step that produces GLA from linoleic acid. Combining the two loads both arms of the pathway onto one rate-limiting enzyme. Preformed GLA is less affected than dietary linoleic acid would be, since it is already past that step.

Borage seed oil supplies gamma-linolenic acid in a triglyceride matrix as evening primrose oil does, at a higher GLA proportion per gram of oil. Taken together they simply add GLA, which means the total intake needs to be read across both rather than from one label. The rest of the fatty acid profile differs between the two oils.

The stratum corneum barrier is built from ceramides, cholesterol and free fatty acids in an ordered lamellar arrangement, and linoleate-containing acylceramides are part of that structure. GLA and its elongation product enter the same epidermal lipid pool. The combination is a structural rationale for skin support, with human comparison data for the pairing itself thin.

Hyaluronic acid binds water in the dermal matrix while GLA feeds the lipid side of barrier function that limits water loss outward. The two address different halves of the same skin hydration picture. Formulators pair them for that reason rather than on the strength of a combination trial.

Collagen peptides supply glycine, proline and hydroxyproline-rich di- and tripeptides to the dermal protein pool, while GLA contributes to the epidermal lipid barrier. They act on different tissue compartments, so their pairing in a skin formula is complementary rather than overlapping. Evidence for the combination as a unit is not what supports this row.

Evening primrose oil is around three quarters polyunsaturated and oxidises readily once pressed. Rosemary extract contributes carnosic acid and carnosol, which chelate pro-oxidant metals and help regenerate tocopherol in the same oil phase. This protects the oil in the container and says nothing about a physiological effect.

Nattokinase acts on fibrin and has been described as affecting platelet behaviour, and omega-6 as well as omega-3 fatty acid supplementation has been reported to attenuate platelet reactivity. Stacking two agents that both push in that direction is worth flagging to anyone on medication that affects clotting. This is a caution row, not a benefit.

Ginger's pungent constituents have been described as inhibiting thromboxane-mediated platelet aggregation, the same general direction as fatty acid supplementation. Combining them is a reason to raise the stack with a clinician before any procedure or alongside anticoagulant medication. Flagging the additive direction is the point here.

Salicin is metabolised to salicylate, which affects platelet cyclooxygenase, while fatty acid supplementation has been reported to attenuate platelet reactivity by a separate route. Two different mechanisms pointing the same way can add up. Anyone on clotting-related medication should discuss the combination first.

Retinoids change keratinocyte turnover and are well known for the dryness and barrier disruption that come with them, and barrier lipids are exactly what GLA feeds into. Evening primrose oil has been studied alongside retinoid therapy for that reason. The relationship is about supporting normal barrier lipid supply, and prescription retinoid use is a conversation for the prescriber.

GLA in evening primrose oil sits at the sn-3 and sn-2 positions of triglycerides and has to be released as free fatty acid or monoacylglycerol before it crosses the enterocyte. Pancreatic lipase does that work, assisted by bile salt emulsification. Where lipase output is low, oil taken with a fat-containing meal is the practical lever.

Bile salts break the swallowed oil into fine droplets and then form the mixed micelles that carry fatty acids to the brush border. Without adequate bile flow a fraction of any seed oil dose is not absorbed. This is standard lipid digestion rather than a special interaction.

Lecithin lowers interfacial tension and produces finer oil droplets, which increases the area available to lipase and bile salts. In liquid and emulsion formats it also keeps the oil dispersed rather than separated. The benefit is delivery and stability, not additional fatty acid.